4-hydroxy-25-desoxyneorollinicin has been researched along with fluorescein-5-isothiocyanate in 2 studies
| Studies (4-hydroxy-25-desoxyneorollinicin) | Trials (4-hydroxy-25-desoxyneorollinicin) | Recent Studies (post-2010) (4-hydroxy-25-desoxyneorollinicin) | Studies (fluorescein-5-isothiocyanate) | Trials (fluorescein-5-isothiocyanate) | Recent Studies (post-2010) (fluorescein-5-isothiocyanate) |
|---|---|---|---|---|---|
| 62 | 0 | 7 | 8,493 | 33 | 2,090 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, FR; Chih, HW; Chiu, HF; Tang, KS; Wu, YC | 1 |
| Chih, TT; Chiu, HF; Hsian, YM; Tseng, CH; Wu, MJ; Wu, YC | 1 |
2 other study(ies) available for 4-hydroxy-25-desoxyneorollinicin and fluorescein-5-isothiocyanate
| Article | Year |
|---|---|
Bullatacin, a potent antitumor annonaceous acetogenin, inhibits proliferation of human hepatocarcinoma cell line 2.2.15 by apoptosis induction.
Topics: Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Death; Cell Division; Culture Media, Conditioned; DNA; Dose-Response Relationship, Drug; Ficoll; Flow Cytometry; Fluorescein-5-isothiocyanate; Furans; Hepatitis B Surface Antigens; Humans; Liver Neoplasms; Propidium; Tumor Cells, Cultured | 2001 |
Bullatacin, a potent antitumor Annonaceous acetogenin, induces apoptosis through a reduction of intracellular cAMP and cGMP levels in human hepatoma 2.2.15 cells.
Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Colforsin; Cyclic AMP; Cyclic GMP; Drug Interactions; Fluorescein-5-isothiocyanate; Furans; Humans; S-Nitrosoglutathione; Tumor Cells, Cultured | 2003 |